Latest news
Zymeworks Inc. Q2 2026: Revenue $4.6M, EPS $(0.62) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTJazz Pharmaceuticals plc Stock 12‑Month Price Target Raised to $285, Implies 13% Upside - TradingViewTradingView · Tue, 04 Aug 2026 16:20:05 GMTElanco (ELAN) Reports Q2: Everything You Need To Know Ahead Of Earnings - TradingViewTradingView · Tue, 04 Aug 2026 03:11:00 GMTJAZZ: Q2 revenue up 16% YoY to $1.21B; 2026 guidance raised on strong portfolio growth - TradingViewTradingView · Mon, 03 Aug 2026 23:31:26 GMTJazz Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Mon, 03 Aug 2026 22:03:49 GMTJazz Pharmaceuticals PLC reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Mon, 03 Aug 2026 21:39:18 GMTJazz Pharmaceuticals (NASDAQ:JAZZ) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales - TradingViewTradingView · Mon, 03 Aug 2026 20:55:52 GMTIreland's Jazz Pharma Q2 revenue beats estimates on Zepzelca higher sales - TradingViewTradingView · Mon, 03 Aug 2026 20:24:36 GMT